ArticleScientific reports2017

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Hui-Fang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.